Results of a pivotal clinical trial among 7,829 women ages 16-35 in East and Southern Africa provide important evidence to help inform women’s choices for contraception and HIV prevention. The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study found no substantial difference in HIV risk among women using the three methods of contraception in the study – the copper-releasing intrauterine device (Cu-IUD), a levonorgestrel (LNG) implant (Jadelle) and depot medroxyprogesterone acetate-intramuscular (DMPA-IM), also known as Depo-Provera.
Today’s judgement by the Gaborone High Court to decriminalize consensual same sex relations is a victory in the battle for equality and freedom to love whoever you choose, Amnesty International said as it called on other African countries to follow Botswana’s inspiring example.
Preventing maternal and child deaths, creating an AIDS-free generation, and protecting communities from infectious disease threats needs efficient pharmaceutical services and treatment with quality medicines.
People with HIV and hepatitis C are no longer at higher risk of end-stage liver disease than people with hepatitis C alone, and the trend is probably associated with the improved effectiveness of antiretroviral treatment, a French study has reported in the journal Hepatology.
The efficacy of first-line antiretroviral therapy (ART) continues to improve, according to an analysis of outcomes in 78,000 people in 181 studies, published in AIDS by Professor Andrew Carr of St Vincent's Hospital in Sydney and colleagues.
In recent years, an overwhelming body of clinical evidence has firmly established the HIV Undetectable = Untransmittable (U=U) concept as scientifically sound, say officials from the National Institutes of Health.
For the first time, a group of 40 nursing and midwifery students from private medical training institutes in the Dar es Salaam area received practical clinical experience at private medical facilities thanks to a pilot designed by SHOPS Plus.